Indiana reports new records in COVID-19 cases, hospitalizations
The Indiana State Department of Health on Wednesday said the seven-day moving average for new COVID-19 cases reached another all-time high of 4,681.
Health Care & Insurance
Articles
Future of business travel unclear as virus upends work life
Work travel represented 21% of the $8.9 trillion spent on global travel and tourism in 2019, according to the World Travel and Tourism Council. How much of that business will return after the pandemic is uncertain.
Trump officials promise fair distribution of Lilly’s new COVID-19 antibody drug
Because of the initial limited supply, the number of doses each state receives will be determined by the number of confirmed cases and hospitalizations in a given week, federal officials said.
Indiana hospitals straining to keep up with COVID-19 patient load
The Indiana Hospital Association on Tuesday warned that medical facilities are struggling to keep up with a record number of hospitalizations. It called on Hoosiers to wear face coverings and practice social distancing.
New study reveals venues that are high-risk areas for spreading coronavirus
Restaurants, gyms and coffee shops rank high among locations where the coronavirus is most likely to spread outside the home. That’s according to a newly published report, based on data from millions of Americans, tracked by their phones.
Supreme Court appears likely to leave Obamacare law in place
Chief Justice John Roberts and Justice Brett Kavanaugh, among the conservative justices, appeared in two hours of arguments to be unwilling to strike down the entire law.
Medical malpractice plaintiffs reach $66M settlement in case against cardiologist
The 262 plaintiffs claimed that the doctor’s practice had implanted pacemakers or defibrillators they didn’t need and routinely scheduled unnecessary procedures.
Indiana reports 63 more COVID-19 deaths, another high in hospitalizations
New cases of COVID-19 in Indiana have exceeded 4,000 for six straight days and topped 2,000 for 20 consecutive days.
Lilly’s COVID-19 treatment expected to be in short supply initially
The initial scarcity of the drug and the logistical complexities of administering it could mute its immediate impact on the pandemic and raise questions about whether it is being distributed to people in the greatest need.
Much at stake as Supreme Court weighs future of Obamacare
What’s at stake has real-world consequences for just about every American, as well as the health care industry, a major source of jobs and tax revenues.
U.S. allows emergency use of Lilly’s COVID-19 antibody drug
The Food and Drug Administration on Monday cleared the experimental drug from Indianapolis-based Eli Lilly and Co. for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. It’s a one-time treatment given through an IV.
Dow climbs more than 800 points as vaccine news revs up markets
Global markets roared Monday, with the Dow Jones industrial average soaring to intraday highs not seen since February.
Trump faces long odds in challenging state vote counts
Republican surrogates for President Donald Trump resumed their legal fight Monday to try to stop the vote count in key battleground states, including Pennsylvania and Michigan.
Fall Creek Place eatery Shoefly cites pandemic for closure
Shoefly Public House suspended operations on Saturday after a staff member tested positive for COVID-19. The initial plan was to reopen, but the owners soon decided to make the closure permanent.
Steak n Shake closes 13 more restaurants amid slowing customer traffic
Steak n Shake revenue plummeted to $78.8 million in the third quarter, down from $141.3 million a year ago.
Stocks skyrocket to record levels on Pfizer’s optimistic vaccine news
Markets were already sharply higher on the U.S. election result when Pfizer said that research shows vaccine shots may be 90% effective at preventing COVID-19, indicating the company is on track this month to file an emergency-use application with U.S. regulators.
Pfizer says COVID-19 vaccine is looking 90% effective
The coronavirus shots, made by Pfizer and its German partner BioNTech, are among 10 possible vaccine candidates in late-stage testing around the world—four of them so far in huge studies in the U.S.
Nursing home COVID-19 cases rise four-fold in surge states
Nursing homes and other long-term care facilities account for about 1% of the U.S. population, but represent 40% of COVID-19 deaths, according to the COVID Tracking Project.
Indiana reports another 4,689 COVID-19 cases; hospitalizations hit another high
The Indiana State Department of Health has reported 262 new COVID-19 deaths over the past seven days, up from 229 the previous week.
FDA panel urges rejection of experimental Alzheimer’s drug
The Biogen drug, known as aducanumab, does not cure or reverse Alzheimer’s, but it might modestly slow the rate of decline.